SCHEMBL22071034

SCHEMBL22071034

CCOC(=O)C1CC=C(c2cccc(CO)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
CDK9 P50750 2/20 0.41
CCNT1 O60563 1/20 0.41
CCR8 P51685 1/20 0.40
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 1/20 0.39
RORC P51449 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
FFAR1 O14842 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12213904 0.87 CDK9 (0.43) KDM4EALDH1A1MAPTCDK9CCNT1
SCHEMBL2508849 0.85 ATM (0.47) KDM4EALDH1A1CDK9CCNT1PKM
SCHEMBL2508847 0.85 ATM (0.47) KDM4EALDH1A1CDK9CCNT1PKM
SCHEMBL7717920 0.85 SMN1; SMN2 (0.44) KDM4EALDH1A1MAPTCDK9CCNT1
SCHEMBL2511131 0.82 CNR2 (0.44) CDK9CCNT1RORCALOX15TSHR
SCHEMBL2511133 0.82 CNR2 (0.44) CDK9CCNT1RORCALOX15TSHR
SCHEMBL22070694 0.81 ALDH1A1 (0.42) CYP4F2CYP4A11KDM4EALDH1A1MAPT
SCHEMBL3248056 0.81 ALDH1A1 (0.50) ALDH1A1MAPTPKMNPSR1NPC1
SCHEMBL2511512 0.80 POLB (0.44) KDM4EALDH1A1MAPTCDK9CCNT1
SCHEMBL2511519 0.80 POLB (0.44) KDM4EALDH1A1MAPTCDK9CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365192-B2 Pyridine compound substituted with azole TAISHO PHARMACEUTICAL CO., LTD. (JP) 2022-06-21 US disclosed
US-20210122741-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE TAISHO PHARMACEUTICAL CO., LTD (JP) 2021-04-29 US disclosed
EP-3666766-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE Taisho Pharmaceutical Co., Ltd. (JP) 2020-06-17 EP disclosed
CN-110914254-A Azole-substituted pyridine compound 大正制药株式会社 2020-03-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122741-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE CYP2C19, CYP4A11, CYP11B1 CYP4F2 20/4885CYP4A11 2/4885KDM4E 169/4885
US-11365192-B2 Pyridine compound substituted with azole CYP2C19, CYP4A11, CYP11B1 CYP4F2 20/4885CYP4A11 2/4885KDM4E 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.